LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)
Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%
LeMaitre Vascular ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
LeMaitre Vascular's ebitda for the twelve months ending Jun 30, 2026 was $87.82M, up 35.5% year over year. For fiscal 2025 it was $78.33M, up 26.6% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $78.33M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.33M | +26.6% |
| FY2024 | Dec 31, 2024 | $61.86M | +33.8% |
| FY2023 | Dec 31, 2023 | $46.23M | +27.5% |
| FY2022 | Dec 31, 2022 | $36.26M | -23.7% |
| FY2021 | Dec 31, 2021 | $47.50M | +27.7% |
| FY2020 | Dec 31, 2020 | $37.18M | +39.8% |
| FY2019 | Dec 31, 2019 | $26.60M | -18.2% |
| FY2018 | Dec 31, 2018 | $32.53M | +29.3% |
| FY2017 | Dec 31, 2017 | $25.16M | +26.3% |
| FY2016 | Dec 31, 2016 | $19.93M | +33.7% |
| FY2015 | Dec 31, 2015 | $14.91M | +54.1% |
| FY2014 | Dec 31, 2014 | $9.67M | +32.3% |
| FY2013 | Dec 31, 2013 | $7.31M | +12.9% |
| FY2012 | Dec 31, 2012 | $6.47M | +13.0% |
| FY2011 | Dec 31, 2011 | $5.73M | +6.2% |
| FY2010 | Dec 31, 2010 | $5.39M | +60.1% |
| FY2009 | Dec 31, 2009 | $3.37M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.06M | +22.7% |
| Q1 FY2026 | Mar 31, 2026 | $20.40M | +34.4% |
| Q4 FY2025 | Dec 31, 2025 | $21.44M | +40.4% |
| Q3 FY2025 | Sep 30, 2025 | $22.93M | +47.2% |
| Q2 FY2025 | Jun 30, 2025 | $18.79M | +12.1% |
| Q1 FY2025 | Mar 31, 2025 | $15.18M | +6.5% |
| Q4 FY2024 | Dec 31, 2024 | $15.27M | +20.7% |
| Q3 FY2024 | Sep 30, 2024 | $15.57M | +34.5% |
| Q2 FY2024 | Jun 30, 2024 | $16.76M | +42.3% |
| Q1 FY2024 | Mar 31, 2024 | $14.26M | +39.4% |
| Q4 FY2023 | Dec 31, 2023 | $12.65M | +36.7% |
| Q3 FY2023 | Sep 30, 2023 | $11.58M | +36.5% |
| Q2 FY2023 | Jun 30, 2023 | $11.78M | +43.1% |
| Q1 FY2023 | Mar 31, 2023 | $10.23M | -0.7% |
| Q4 FY2022 | Dec 31, 2022 | $9.26M | -17.3% |
| Q3 FY2022 | Sep 30, 2022 | $8.48M | -29.3% |
| Q2 FY2022 | Jun 30, 2022 | $8.23M | -40.1% |
| Q1 FY2022 | Mar 31, 2022 | $10.30M | -2.5% |
| Q4 FY2021 | Dec 31, 2021 | $11.19M | -7.4% |
| Q3 FY2021 | Sep 30, 2021 | $12.00M | -5.5% |
| Q2 FY2021 | Jun 30, 2021 | $13.74M | +111.1% |
| Q1 FY2021 | Mar 31, 2021 | $10.57M | +79.4% |
| Q4 FY2020 | Dec 31, 2020 | $12.08M | +89.7% |
| Q3 FY2020 | Sep 30, 2020 | $12.70M | +75.2% |
| Q2 FY2020 | Jun 30, 2020 | $6.51M | -10.3% |
| Q1 FY2020 | Mar 31, 2020 | $5.89M | +3.0% |
| Q4 FY2019 | Dec 31, 2019 | $6.37M | -24.3% |
| Q3 FY2019 | Sep 30, 2019 | $7.25M | +29.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.26M | -42.4% |
| Q1 FY2019 | Mar 31, 2019 | $5.72M | -3.0% |
| Q4 FY2018 | Dec 31, 2018 | $8.41M | +13.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.62M | -7.2% |
| Q2 FY2018 | Jun 30, 2018 | $12.61M | +93.4% |
| Q1 FY2018 | Mar 31, 2018 | $5.90M | +14.0% |
| Q4 FY2017 | Dec 31, 2017 | $7.41M | +53.0% |
| Q3 FY2017 | Sep 30, 2017 | $6.06M | -2.1% |
| Q2 FY2017 | Jun 30, 2017 | $6.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.17M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.84M | – |
| Q3 FY2016 | Sep 30, 2016 | $6.19M | – |
See a number that looks wrong?